Opexa Therapeutics (OPXA) Reports Q3 Loss Per Share of $0.42
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Basic and diluted loss per share: -0.28
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Basic and diluted loss per share: -0.28
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Opexa Therapeutics (NASDAQ: OPXA) reported Q3 EPS of ($0.42), versus ($1.11) reported last year. Revenue for the quarter came in at $726 thousand, versus $307 thousand reported last year.
For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Robinhood shares climb on summit momentum and analyst support
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
